[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336435-105":59,"doc-detail-336435-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","upregulated-sae1-drives-tumorigenesis-and-is-associated-with-poor-clinical-outcomes-in-breast-cancer-research-article","Upregulated SAE1 Drives Tumorigenesis and Is Associated with Poor Clinical Outcomes in Breast Cancer - Research Article","","Background: This study analyzes the expression of SUMO activating enzyme subunit 1 (SAE1) in breast cancer and evaluates its biological roles and associated signaling pathways using bioinformatics and laboratory experiments. Methods: SAE1 levels were compared between breast cancer and normal tissues, including correlations with clinicopathologic features and prognosis, using TCGA and GEO datasets and immunohistochemistry in 79 patient samples. Cellular effects were tested via CCK-8, colony formation, flow cytometry, and western blots, with GSEA and PI3K/AKT/mTOR pathway assessment after SAE1 knockdown. Results: SAE1 mRNA/protein were higher in tumors; overexpression related to aggressive characteristics and poorer survival. Conclusion: SAE1 promotes proliferation and cell-cycle progression in vitro, links to mTORC1/PI3K-AKT-mTOR pathways, and may serve as a breast cancer treatment target.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/upregulated-sae1-drives-tumorigenesis-and-is-associated-with-poor-clinical-outcomes-in-breast-cancer-research-article/336435/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/upregulated-sae1-drives-tumorigenesis-and-is-associated-with-poor-clinical-outcomes-in-breast-cancer-research-article/336435.png","ImageObject",300,407,{"name":92,"@type":93},"Maeve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the purpose of this study on SAE1 in breast cancer?","Question",{"text":112,"@type":113},"To analyze SAE1 expression in breast cancer and assess its biological function and related signaling pathways using bioinformatics and in vitro experiments.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was SAE1 expression measured in breast cancer tissues and cells?",{"text":117,"@type":113},"SAE1 mRNA/protein were assessed using bioinformatics and immunohistochemistry in 79 patient tissue samples, and protein changes were evaluated by western blots in SAE1-siRNA transfected cells.",{"name":119,"@type":110,"acceptedAnswer":120},"What clinical and prognostic associations were found with SAE1 overexpression?",{"text":121,"@type":113},"SAE1 overexpression was linked to tumor size, tumor-node-metastasis stage, hormone receptors, HER2 status, and triple-negative status, and patients with high SAE1 showed worse overall survival, recurrence-free survival, and distant metastasis-free survival.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336435,1790135395,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},5909877438554,"https://ap-avatar.wpscdn.com/avatar/5600025385ad2bf12a7?_k=1778553567797529272","Wiley  \nThe Breast Journal  \nVolume 2024, Article ID 2981722, 10 pages [https://doi.org/10.1155/2024/2981722](https://doi.org/10.1155/2024/2981722)  \nResearch Article  \nUpregulated SAE1 Drives Tumorigenesis and Is Associated with Poor Clinical Outcomes in Breast Cancer  \nHong Liu,1 Jing Wang,2,3,4 Yunhai Li, 1 Feng Luo , 1 and Lei Xing 1  \n1 Department of Breast and Tyroid Surgery, Te First Afliated Hospital of Chongqing Medical University, No. 1 Youyi Rd, Chongqing, 400016, China  \n2 Chongqing Key Laboratory of Molecular Oncology and Epigenetics,  \nTe First Afliated Hospital of Chongqing Medical University, No. 1 Youyi Rd, Chongqing, 400016, China  \n3 Department of Head, Neck and Breast Surgery, Te First Afliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230031, Anhui, China  \n4 Department of Head, Neck and Breast Surgery, Anhui Provincial Cancer Hospital, Hefei, 230031, Anhui, China  \nCorrespondence should be addressed to Feng Luo; luofeng201413@163.com and Lei Xing; [tiger861220@126.com](tiger861220@126.com)  \nReceived 29 January 2024; Revised 14 May 2024; Accepted 16 June 2024  \nAcademic Editor: Pranshu Sahgal  \nCopyright © 2024 Hong Liu et al. Tis is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.  \nBackground. Te purpose of this study was to analyze SUMO activating enzyme subunit 1 (SAE1) expression in breast cancer (BC). Trough bioinformatics analysis and in vitro experiments, the biological function and possibly associated signal pathways of SAE1 in BC were further analyzed. Methods. Bioinformatics analysis was applied to analyze SAE1 expression in BC and normal breast tissues, its relationship with clinicopathologic characteristics and prognosis in BC patients, and data from the Cancer Genome Atlas database and Gene Expression Omnibus dataset. We performed immunohistochemistry to analyze SAE1 expression in BC tissues and paracancer tissues in 79 breast cancer patients. BC cell proliferation was detected with the Cell Counting Kit-8 and by the colony formation assay. Cell cycle progression was analyzed by fow cytometry, and the expression of cell cycle-related proteins (E2F1, cyclin D3, and cyclin-dependent kinase 2) was determined by western blots in SAE1 small interfering RNA (siRNA) transfected cells. Te GSE1456 dataset was used to analyze possible signal pathways associated with SAE1 by gene set enrichment analysis (GSEA), and the expression of PI3K/AKT/mTOR pathway-related proteins (such as p-PI3K, p-AKT, and mTOR) in SAE1-siRNA cells was detected by western blots. Results. Te bioinformatics and immunohistochemical results showed that SAE1 mRNA and protein expression in BC tissues were signifcantly higher than those in normal tissues. Te SAE1 overexpression was signifcantly associated with the tumor size, tumor-node-metastasis stage, estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, and whether or not it was a triple-negative BC. Patients with SAE1 overexpression had a worse overall survival (OS), recurrence-free survival (RFS), and distant metastasis-free survival compared with lower expression patients. Multivariate Cox regression analysis showed that SAE1 maybe an independent prognostic factor for OS ofBC patients. Te proliferation and cell cycle process of BC cells were inhibited by SAE1-siRNA in vitro. Te result of GSEA showed that SAE1 was signifcantly associated with 12 gene sets, including unfolded protein reaction, DNA repair, oxidative phosphorylation, and cell cycle, among others. Additionally, two signal pathways, mTORC1 and PI3K/Akt/mTOR, were signifcantly correlated with SAE1 overexpression. Western blots confrmed that the expression of PI3K/Akt/mTOR pathway-related proteins (p-PI3K, p-AKT, and mTOR) in BC cells was decreased after knocking d","cbCait7xZEdoyqBZ","https://ap.wps.com/l/cbCait7xZEdoyqBZ","pdf",1604697,"English","# Background\n# Methods\n## Human BC Tissue Specimens\n# Results\n# Conclusion","[{\"question\":\"What was the purpose of this study on SAE1 in breast cancer?\",\"answer\":\"To analyze SAE1 expression in breast cancer and assess its biological function and related signaling pathways using bioinformatics and in vitro experiments.\"},{\"question\":\"How was SAE1 expression measured in breast cancer tissues and cells?\",\"answer\":\"SAE1 mRNA/protein were assessed using bioinformatics and immunohistochemistry in 79 patient tissue samples, and protein changes were evaluated by western blots in SAE1-siRNA transfected cells.\"},{\"question\":\"What clinical and prognostic associations were found with SAE1 overexpression?\",\"answer\":\"SAE1 overexpression was linked to tumor size, tumor-node-metastasis stage, hormone receptors, HER2 status, and triple-negative status, and patients with high SAE1 showed worse overall survival, recurrence-free survival, and distant metastasis-free survival.\"}]","Upregulated SAE1 Drives Tumorigenesis and Is Associated with Poor Clinical Outcomes in Breast Cancer - Research Article | PDF",1790015047,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b6bd561a550749deb643be96c0530733.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/78768919dc2ef13e62eca1c38f1eba84.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e85f4738768c923ad6b3efd76d53887e.webp",981,1307,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f63faf13f5a82d4c089defa0b33a62c9.webp",980,1306]